Ovarian Cancer Stem Cells with High ROR1 Expression Serve as a New Prophylactic Vaccine for Ovarian Cancer

Tumor vaccines offer a number of advantages for cancer treatment. In the study, the vaccination with cancer stem cells (CSCs) with high expression of the type I receptor tyrosine kinase-like orphan receptor (ROR1) was evaluated in a murine model for the vaccine's immunogenicity and protective e...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Di, Yu, Xiaoyu, Wang, Jing, Hui, Xu, Zhang, Yunxia, Cai, Yunlang, Ren, Mulan, Guo, Mei, Zhao, Fengshu, Dou, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441513/
https://www.ncbi.nlm.nih.gov/pubmed/31008116
http://dx.doi.org/10.1155/2019/9394615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441513/
https://www.ncbi.nlm.nih.gov/pubmed/31008116
http://dx.doi.org/10.1155/2019/9394615

Ejemplares similares